Celldex Therapeutics Inc: Leerink Partners cuts target price to $70 from $78
CLDX•Related News
Ukraine health ministry accepts Valion Bio Entolimod dossier for regulatory review
VBIO•
Novagold Resources to acquire Paulson's Donlin interests in $4.2 billion deal
NG•
City Holding Q2 net interest income rises as loan yields improve
CHCO•
Baidu applies to convert Hong Kong secondary listing to dual-primary status
BIDU•
MakeMyTrip to report fiscal Q1 results before markets open
MMYT•